近期戒断的慢性使用者的大麻催吐综合征:评估与干预

Y. Elsherif, Saria Gouher, Mutaz Mohsin Abualhab, Joseph El-Khoury
{"title":"近期戒断的慢性使用者的大麻催吐综合征:评估与干预","authors":"Y. Elsherif, Saria Gouher, Mutaz Mohsin Abualhab, Joseph El-Khoury","doi":"10.17816/cp15473","DOIUrl":null,"url":null,"abstract":"BACKGROUND: Cannabis Hyperemesis Syndrome (CHS) is a condition characterized by episodic bursts of vomitingand abdominal pain linked to cannabis use. The clinical picture mimics an acute abdomen and is often misdiagnosed,especially when the patient avoids reporting their cannabis use for legal reasons.CASE REPORT: We report on the case of a 33-year-old man that was brought to the emergency room with a history of3 days of non-bloody, non-projectile, and non-bilious brownish vomit, coupled with severe epigastric and left hypochondriacpain, and a slight fever. He was a daily cannabis user for several years and had stopped using a week or so before theonset of the symptoms, as he was traveling to a country with more restrictive cannabis laws. His condition deterioratedrapidly, followed by emergency room attendance, thorough diagnostic work-up, and unsuccessful interventions, includingintravenous treatment with the anti-emetic Ondansetron. The patient was referred to a psychiatrist after a suspectedpsychogenic etiology by the medical team. The history was suggestive of CHS and also included anxious, depressedmood with ‘brain fog’. The abdominal pain was the most severe complaint. A combination of tramadol, promethazine,and mirtazapine given on an outpatient basis led to full recovery within 10 days.CONCLUSION: CHS can occur soon after the interruption of chronic cannabis use and overlap with withdrawal symptom.A combination of anti-histaminergic, opioid-based medication, and antidepressant mirtazapine seemed an effectivetreatment of CHS, which resulted in a relatively quick recovery.","PeriodicalId":262442,"journal":{"name":"Consortium Psychiatricum","volume":"11 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cannabis Hyperemesis Syndrome in a Recently Abstinent Chronic User: Assessment and Intervention\",\"authors\":\"Y. Elsherif, Saria Gouher, Mutaz Mohsin Abualhab, Joseph El-Khoury\",\"doi\":\"10.17816/cp15473\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"BACKGROUND: Cannabis Hyperemesis Syndrome (CHS) is a condition characterized by episodic bursts of vomitingand abdominal pain linked to cannabis use. The clinical picture mimics an acute abdomen and is often misdiagnosed,especially when the patient avoids reporting their cannabis use for legal reasons.CASE REPORT: We report on the case of a 33-year-old man that was brought to the emergency room with a history of3 days of non-bloody, non-projectile, and non-bilious brownish vomit, coupled with severe epigastric and left hypochondriacpain, and a slight fever. He was a daily cannabis user for several years and had stopped using a week or so before theonset of the symptoms, as he was traveling to a country with more restrictive cannabis laws. His condition deterioratedrapidly, followed by emergency room attendance, thorough diagnostic work-up, and unsuccessful interventions, includingintravenous treatment with the anti-emetic Ondansetron. The patient was referred to a psychiatrist after a suspectedpsychogenic etiology by the medical team. The history was suggestive of CHS and also included anxious, depressedmood with ‘brain fog’. The abdominal pain was the most severe complaint. A combination of tramadol, promethazine,and mirtazapine given on an outpatient basis led to full recovery within 10 days.CONCLUSION: CHS can occur soon after the interruption of chronic cannabis use and overlap with withdrawal symptom.A combination of anti-histaminergic, opioid-based medication, and antidepressant mirtazapine seemed an effectivetreatment of CHS, which resulted in a relatively quick recovery.\",\"PeriodicalId\":262442,\"journal\":{\"name\":\"Consortium Psychiatricum\",\"volume\":\"11 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Consortium Psychiatricum\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17816/cp15473\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Consortium Psychiatricum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17816/cp15473","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

背景:大麻剧吐综合征(CHS)是一种以与吸食大麻有关的阵发性呕吐和腹痛为特征的疾病。临床表现与急腹症相似,经常被误诊,尤其是当患者出于法律原因避免报告其吸食大麻的情况时。病例报告:我们报告了一例 33 岁男子的病例,该男子被送入急诊室,病史为 3 天的非血性、非喷射性、非淤血性褐色呕吐物,伴有严重的上腹部和左下腹疼痛,以及轻微发烧。几年来,他每天都吸食大麻,在症状出现前一周左右,他停止了吸食大麻,因为他要去一个大麻法律限制更严格的国家旅行。他的病情迅速恶化,随后到急诊室就诊,进行了全面的诊断检查,并采取了包括静脉注射止吐药昂丹司琼在内的干预措施,但均未奏效。医疗小组怀疑患者的病因是精神因素,于是将其转诊至精神科医生。病史提示患者患有 CHS,还包括焦虑、情绪低落和 "脑雾"。腹痛是最严重的主诉。在门诊给予曲马多、异丙嗪和米氮平联合用药后,患者在 10 天内完全康复。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cannabis Hyperemesis Syndrome in a Recently Abstinent Chronic User: Assessment and Intervention
BACKGROUND: Cannabis Hyperemesis Syndrome (CHS) is a condition characterized by episodic bursts of vomitingand abdominal pain linked to cannabis use. The clinical picture mimics an acute abdomen and is often misdiagnosed,especially when the patient avoids reporting their cannabis use for legal reasons.CASE REPORT: We report on the case of a 33-year-old man that was brought to the emergency room with a history of3 days of non-bloody, non-projectile, and non-bilious brownish vomit, coupled with severe epigastric and left hypochondriacpain, and a slight fever. He was a daily cannabis user for several years and had stopped using a week or so before theonset of the symptoms, as he was traveling to a country with more restrictive cannabis laws. His condition deterioratedrapidly, followed by emergency room attendance, thorough diagnostic work-up, and unsuccessful interventions, includingintravenous treatment with the anti-emetic Ondansetron. The patient was referred to a psychiatrist after a suspectedpsychogenic etiology by the medical team. The history was suggestive of CHS and also included anxious, depressedmood with ‘brain fog’. The abdominal pain was the most severe complaint. A combination of tramadol, promethazine,and mirtazapine given on an outpatient basis led to full recovery within 10 days.CONCLUSION: CHS can occur soon after the interruption of chronic cannabis use and overlap with withdrawal symptom.A combination of anti-histaminergic, opioid-based medication, and antidepressant mirtazapine seemed an effectivetreatment of CHS, which resulted in a relatively quick recovery.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信